© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.
Cameron Santoro is an associate editor for The Center for Biosimilars®, The American Journal of Managed Care® (AJMC), and AJMC.com.
August 20, 2024
Article
Biosimilar CT-P42 demonstrated comparable efficacy, safety, and tolerability to reference aflibercept in treating diabetic macular edema (DME).
August 18, 2024
Article
In an interview, Ha Kung Wong, an intellectual property attorney, explained that the Biologics Price Competition and Innovation Act of 2009 provides a structured but optional "patent dance" for biosimilars, which helps streamline patent disputes, potentially reducing litigation and encouraging early settlements.
August 16, 2024
Video
Here are the top 5 biosimilar articles for the week of August 12, 2024.
August 11, 2024
Video
Ivo Abraham, PhD, RN, University of Arizona Cancer Center, focused on the cost savings generated by biosimilars and how crucial reinvesting those savings into broader patient access to care is. This approach has the potential to improve health care equity and expand treatment options for patients.
August 09, 2024
Video
Here are the top 5 biosimilar articles for the week of August 5, 2024.
August 08, 2024
Article
In a comprehensive analysis, the biosimilar SB15 exhibited high similarity to reference aflibercept in terms of physicochemical and biological properties.
August 02, 2024
Video
Here are the top 5 biosimilar articles for the week of July 29, 2024.
July 28, 2024
Video
Ivo Abraham, PhD, RN, University of Arizona Cancer Center, recognizes the importance of stringent safety measures for biosimilar approvals. However, he advocates for utilizing statistical models and placing emphasis on postmarket safety data collection.
July 26, 2024
Video
Here are the top 5 biosimilar articles for the week of July 22, 2024.
July 19, 2024
Video
Here are the top 5 biosimilar articles for the week of July 15, 2024.